Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-26-001452
Filing Date
2026-01-09
Accepted
2026-01-09 07:48:09
Documents
4
Period of Report
2026-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1767962884.html 3  
1 FORM 3 wk-form3_1767962884.xml 3 16160
2 EX-24 keschpoa.htm EX-24 853
3 GRAPHIC keschpoa001.jpg GRAPHIC 212264
4 GRAPHIC keschpoa002.jpg GRAPHIC 61829
  Complete submission text file 0001628280-26-001452.txt   395997
Mailing Address 10 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 10 SYLVAN WAY PARSIPPANY NJ 07054 973-822-7000
Zoetis Inc. (Issuer) CIK: 0001555280 (see all company filings)

EIN.: 460696167 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ZOETIS INC. 10 SYLVAN WAY PARSIPPANY NJ 07054
Business Address
Esch Kevin (Reporting) CIK: 0002099914 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35797 | Film No.: 26521371